Novel antidiabetic medications for non-alcoholic fatty liver disease with type 2 diabetes mellitus
Author:
Affiliation:
1. Division of Hepatology and Pancreatology, Department of Internal Medicine; Aichi Medical University; Nagakute Japan
2. Department of Gastroenterology and Hepatology; Kyoto Prefectural University of Medicine; Kyoto Japan
Publisher
Wiley
Subject
Infectious Diseases,Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/hepr.12856/fullpdf
Reference100 articles.
1. Causes of death in Japanese diabetics: a questionnaire survey of 18,385 diabetics over a 10-year period;Hotta;J Diabetes Investig,2010
2. Global epidemiology of nonalcoholic fatty liver disease - Meta-analytic assessment of prevalence, incidence, and outcomes;Younossi;Hepatology,2016
3. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association;Chalasani;Hepatology,2012
4. Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis;Watanabe;J Gastroenterol,2015
5. EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease;European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO);J Hepatol,2016
Cited by 54 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Comparative Efficacy of Magnetic Resonance Cholangiopancreatography vs. Percutaneous Transhepatic Cholangiography With Percutaneous Transhepatic Biliary Drainage Stenting in Evaluating Obstructive Jaundice: A Prospective Study in South India;Cureus;2024-07-24
2. The Efficacy of Empagliflozin in Combination with Pioglitazone on the Improvement of Fatty Liver Disease in Patients with Type 2 Diabetes;Annals of Military and Health Sciences Research;2024-05-24
3. Linalool attenuates lipid accumulation and oxidative stress in metabolic dysfunction-associated steatotic liver disease via Sirt1/Akt/PPRA-α/AMPK and Nrf-2/HO-1 signaling pathways;Clinics and Research in Hepatology and Gastroenterology;2023-12
4. ZSP1601, a novel pan-phosphodiesterase inhibitor for the treatment of NAFLD, A randomized, placebo-controlled phase Ib/IIa trial;Nature Communications;2023-10-12
5. Clinical effectiveness and pharmacokinetics of gliflozin from the point of view of individual genetic characteristics: A review;Terapevticheskii arkhiv;2023-10-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3